Articles
The growth of drug development in emerging markets

The growth of drug development in emerging markets

Continuing our interview series, Nathaniel Ramuthaga discusses with pharmaphorum how the clinical research environment is developing in the emerging markets. It seems that an ever increasing volume of clinical study work is being conducted outside the mature global pharma markets...

Articles
Market Access in Europe: The view ahead

Market Access in Europe: The view ahead

Following Cegedim Dendrite’s recent research into European market access for drugs, pharmaphorum interviewed UK General Manager David Round to hear his perspective first-hand. As a key partner supporting the pharma industry’s initiatives to engage with an increasingly diverse customer base, Cegedim Dendrite recently conducted...

Articles
Margot James MP presents the PM Society annual lecture

Margot James MP presents the PM Society annual lecture

Paul Tunnah attends the UK PM Society’s annual lecture and finds a sympathetic government voice to the pharma industry in Margot James MP. Every year the UK’s PM Society holds its annual lecture, inviting a guest speaker to address the assembled audience of pharma...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more